{"id":"W4407762960","doi":"10.1016/j.ijgc.2025.101697","title":"Patient-Reported Outcomes With Pembrolizumab Plus Chemoradiotherapy For High-Risk, Locally Advanced Cervical Cancer: Interim Analysis 2 Results From The Randomised, Double-Blind, Phase 3 ENGOT-Cx11/GOG-3047/KEYNOTE-A18 Study","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Interim; Pembrolizumab; Interim analysis; Cervical cancer; Chemoradiotherapy; Oncology; Internal medicine; Gynecology; Clinical trial; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004047755,0.001576457,0.00454992,0.0004288682,0.0005171625,0.001395353,0.0009491249,0.001770084,0.004759729],"category_scores_gemma":[0.003585621,0.0006721469,0.006042202,0.0004524448,0.0007085739,0.001434897,0.0005869186,0.00347357,0.0008565709],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008798568,"about_ca_system_score_gemma":0.001163615,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001026999,"about_ca_topic_score_gemma":0.001636203,"domain_scores_codex":[0.9977766,0.00124371,0.0001548658,0.0002826738,0.0001950294,0.0003471111],"domain_scores_gemma":[0.9977605,0.0008323436,0.0006723072,0.0002547139,0.000130255,0.0003498315],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9716447,0.002531209,0.002083966,0.0005775412,0.004673522,0.00002825606,0.00003686807,0.0008726239,0.001553773,0.00004126367,0.0007692435,0.01518715],"study_design_scores_gemma":[0.7801286,0.1623446,0.04193878,0.0001526736,0.01091361,0.00008337602,0.00005615893,0.001283902,0.001468949,0.0003178324,0.001234799,0.00007677913],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9835776,0.007150798,0.0008758198,0.0004651145,0.0003300259,0.001356045,0.004205341,0.0001031858,0.001935912],"genre_scores_gemma":[0.9887055,0.001482972,0.001231764,0.0006768812,0.0002598713,0.002339749,0.003620611,0.0000344828,0.001648153],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004759729,"threshold_uncertainty_score":0.02140683,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03861104697851629,"score_gpt":0.3862248945327503,"score_spread":0.347613847554234,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}